Publications — Radcliffe Department of Medicine

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy.

Mahmod M. et al, (2022), J Cardiovasc Magn Reson, 24

PHACTR1 modulates vascular compliance but not endothelial function: a translational study.

Wood A. et al, (2022), Cardiovasc Res

Provocation Testing and Therapeutic Response in a Newly Described Channelopathy: RyR2 Calcium Release Deficiency Syndrome.

Ormerod JOM. et al, (2021), Circ Genom Precis Med

Rare coding variants in 35 genes associate with circulating lipid levels-A multi-ancestry analysis of 170,000 exomes.

Hindy G. et al, (2021), Am J Hum Genet

The power of genetic diversity in genome-wide association studies of lipids.

Graham SE. et al, (2021), Nature

Author Correction: Landscape of multi-nucleotide variants in 125,748 human exomes and 15,708 genomes (Nature Communications, (2020), 11, 1, (2539), 10.1038/s41467-019-12438-5)

Wang Q. et al, (2021), Nature Communications, 12

Association Between Sarcomeric Variants in Hypertrophic Cardiomyopathy and Myocardial Oxygenation: Insights From a Novel Oxygen-Sensitive Cardiovascular Magnetic Resonance Approach.

Raman B. et al, (2021), Circulation, 144, 1656 - 1658

Maximal Wall Thickness Measurement in Hypertrophic Cardiomyopathy: Biomarker Variability and its Impact on Clinical Care.

Captur G. et al, (2021), JACC Cardiovasc Imaging, 14, 2123 - 2134

Predictors of Major Atrial Fibrillation Endpoints in the National Heart, Lung, and Blood Institute HCMR.

Kramer CM. et al, (2021), JACC Clin Electrophysiol, 7, 1376 - 1386

Robust estimates of heritable coronary disease risk in individuals with type 2 diabetes.

Grace C. et al, (2021), Genet Epidemiol

Incremental value of left atrial booster and reservoir strain in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study.

Raman B. et al, (2021), J Cardiovasc Magn Reson, 23

Toward Replacing Late Gadolinium Enhancement With Artificial Intelligence Virtual Native Enhancement for Gadolinium-Free Cardiovascular Magnetic Resonance Tissue Characterization in Hypertrophic Cardiomyopathy.

Zhang Q. et al, (2021), Circulation, 144, 589 - 599

Data-driven modelling of mutational hotspots and in silico predictors in hypertrophic cardiomyopathy.

Waring A. et al, (2021), J Med Genet, 58, 556 - 564

FGL1 as a modulator of plasma D-dimer levels: Exome-wide marker analysis of plasma tPA, PAI-1, and D-dimer.

Thibord F. et al, (2021), J Thromb Haemost, 19, 2019 - 2028

CalTrack: High-Throughput Automated Calcium Transient Analysis in Cardiomyocytes.

Psaras Y. et al, (2021), Circ Res, 129, 326 - 341

Time to Think Differently About Sarcomere-Negative Hypertrophic Cardiomyopathy.

Watkins H., (2021), Circulation, 143, 2415 - 2417

Rationale and design of the African Cardiomyopathy and Myocarditis Registry Program: The IMHOTEP study.

Kraus SM. et al, (2021), Int J Cardiol, 333, 119 - 126

The trans-ancestral genomic architecture of glycemic traits.

Chen J. et al, (2021), Nat Genet, 53, 840 - 860

Heritability and family-based GWAS analyses of the N-acyl ethanolamine and ceramide plasma lipidome.

McGurk KA. et al, (2021), Hum Mol Genet, 30, 500 - 513

A titan of Cardiovascular Research: Professor Peter Sleight (1929-2020).

Channon KM. and Watkins H., (2021), Cardiovasc Res, 117, e64 - e66

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?